Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 50, Issue 52, 2003, Pages 1101-1104

  Uenishi, Takahiro ^a   Kubo, Shoji ^a   Hirohashi, Kazuhiro ^a   Yamamoto, Takatsugu ^a   Ogawa, Masao ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokeratin 7; Hepatitis B virus; Hepatocyte

Indexed keywords

AMINOTRANSFERASE; CYTOKERATIN 7; MONOCLONAL ANTIBODY;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STEM CELL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KERATINS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0037662893     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Eyken P, Sciot R, Desmet VJ: A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express bile duct-type cytokeratins. Histopathology 1988; 13:605-617.
2. Lai YS, Thung SN, Gerber MA, Chen ML, Scheffner F: Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. Arch Pathol Lab Med 1989; 113:134-138.
3. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK: Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154:537-541.
4. Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ: Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 19:788-799.
5. Osborn M, Van Lessen G, Weber K, Kloppel G, Altmannsberger M: Different diagnosis of gastrointestinal carcinoma by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986; 55:497-504.
6. Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV: The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988; 12:187-197.
7. Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE: Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J Pathol 1988; 156:305-310.
8. Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA: Identification of bipotential progenitor cells in human liver development. Hepatology 1996; 23:476-481.
9. Haque S, Haruna Y, Saito K, Nalesnik MA, Atillasoy E, Thung SN, Gerber MA: Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996; 75:699-705.
10. Roskams T, De Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V: Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998; 29:455-463.
11. Libbrecht L, Desmet V, Van Damme B, Roskams T: The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 2000; 33:76-84.
12. Tee LB, Kirilak Y, Huang WH, Smith PG, Morgan RH, Yeoh GC: Dual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rat liver. Carcinogenesis 1996; 17:251-259.
13. Sell S, Dunsford HA: Evidence for the stem cell origin of hepatocellular carcinoma and cholangioma. Am J Pathol 1989; 134:1347-1363.
14. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ: Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol 1988; 19:562-568.
15. Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS: Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992; 16:1327-1333.
16. Hsia CC, Thorgeirsson SS, Tabor E: Expression of hepatitis B surface and core antigens and transforming growth factor-α in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol 1994; 43:216-221.
17. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462 503.
18. Liver Cancer Study Group of Japan: Classification of Primary Liver Cancer, 1st English Edition. Tokyo: Kanehara, 1997.
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis; diagnosis, grading and staging. Hepatology 1994; 19:1513-1520.
20. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY: Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: clinical and biological implications. Am J Pathol 1996; 149:1167-1175.
21. Kumada T, Nakao S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, Sassa T: Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25:87.
22. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, shuto T, Okuda T, Yamamoto T, Ikebe T, Wakasa K: Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Hepatogastroenterology 1999; 46:3212.
23. Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Yamamoto T, Ikebe T, Wakasa K, Nishiguchi S, Kinoshita H: Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer 2000; 88:1016-1024.